E
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Ethan M. Clement's research focuses on neurological disorders and treatments, with recent publications investigating the vulnerability of specific interneurons in mouse models of temporal lobe epilepsy and syndecan-1's role in myeloma aggressiveness. Clement has authored 29 publications, accumulating 708 citations and an h-index of 12. Their work also touches upon broader health and medical research impacts, as indicated by the inclusion of MeSH terms such as Humans, Female, Male, and various animal models in their scholarly output.
Metrics
- h-index: 12
- Publications: 29
- Citations: 716
Selected Publications
-
A 61‐year‐old with heavy tobacco use (2023)
-
Vulnerability of cholecystokinin-expressing GABAergic interneurons in the unilateral intrahippocampal kainate mouse model of temporal lobe epilepsy (2021)
Collaboration Network
Top Collaborators
Young‐Jin Kang
University of Arkansas for Medical Sciences (US)
1 shared publication
- Vulnerability of cholecystokinin-expressing GABAergic interneurons in the unilateral intrahippocampal kainate mouse model of temporal lobe epilepsy
In‐Hyun Park
Yale Cancer Center (US)
1 shared publication
- Vulnerability of cholecystokinin-expressing GABAergic interneurons in the unilateral intrahippocampal kainate mouse model of temporal lobe epilepsy
Lazar J. Greenfield
UConn Health (US)
1 shared publication
- Vulnerability of cholecystokinin-expressing GABAergic interneurons in the unilateral intrahippocampal kainate mouse model of temporal lobe epilepsy
Bret N. Smith
University of Kentucky (US)
1 shared publication
- Vulnerability of cholecystokinin-expressing GABAergic interneurons in the unilateral intrahippocampal kainate mouse model of temporal lobe epilepsy
Sang‐Hun Lee
University of Kentucky (US)
1 shared publication
- Vulnerability of cholecystokinin-expressing GABAergic interneurons in the unilateral intrahippocampal kainate mouse model of temporal lobe epilepsy
Lindsay Tjiattas‐Saleski
Prisma Health (US)
1 shared publication
- A 61‐year‐old with heavy tobacco use
Laurie Baert
Inserm (FR)
1 shared publication
- 3-O sulfation of syndecan-1 mediated by the sulfotransferase HS3ST3a1 enhances myeloma aggressiveness
Benoît Manfroi
Université Grenoble Alpes (FR)
1 shared publication
- 3-O sulfation of syndecan-1 mediated by the sulfotransferase HS3ST3a1 enhances myeloma aggressiveness
Marisol Quintero
Centre National de la Recherche Scientifique (FR)
1 shared publication
- 3-O sulfation of syndecan-1 mediated by the sulfotransferase HS3ST3a1 enhances myeloma aggressiveness
O. Chavarria
Université Grenoble Alpes (FR)
1 shared publication
- 3-O sulfation of syndecan-1 mediated by the sulfotransferase HS3ST3a1 enhances myeloma aggressiveness
Pierre-Vincent Barbon
Université Grenoble Alpes (FR)
1 shared publication
- 3-O sulfation of syndecan-1 mediated by the sulfotransferase HS3ST3a1 enhances myeloma aggressiveness
Andreas Zeller
University Hospital of Geneva (CH)
1 shared publication
- 3-O sulfation of syndecan-1 mediated by the sulfotransferase HS3ST3a1 enhances myeloma aggressiveness
Toin van Kuppevelt
Radboud University Nijmegen (NL)
1 shared publication
- 3-O sulfation of syndecan-1 mediated by the sulfotransferase HS3ST3a1 enhances myeloma aggressiveness
Nathalie Stürm
Centre National de la Recherche Scientifique (FR)
1 shared publication
- 3-O sulfation of syndecan-1 mediated by the sulfotransferase HS3ST3a1 enhances myeloma aggressiveness
Jérôme Moreaux
Institut de Génétique Humaine (FR)
1 shared publication
- 3-O sulfation of syndecan-1 mediated by the sulfotransferase HS3ST3a1 enhances myeloma aggressiveness
Similar Researchers
Based on overlapping research topics
Leila Bagherzadeh
University of Arkansas for Medical Sciences
Neurological disorders and treatments
Health and Medical Research Impacts
Neuroscience and Neuropharmacology Research
Ashley M. Benton
University of Arkansas for Medical Sciences
Neurological disorders and treatments
Cancer-related molecular mechanisms research
Health and Medical Research Impacts
Srilatha Thadur
University of Arkansas for Medical Sciences
Neurological disorders and treatments
Health and Medical Research Impacts
Neuroscience and Neuropharmacology Research
Brianna J. Iverson
University of Arkansas at Fayetteville
Neurological disorders and treatments
Health and Medical Research Impacts
Neuroscience and Neuropharmacology Research
U Thaung Shwe
University of Arkansas for Medical Sciences
Neurological disorders and treatments
Epilepsy research and treatment
Neuroscience and Neuropharmacology Research
Inha Baek
University of Arkansas at Fayetteville
Neurological disorders and treatments
Cancer-related molecular mechanisms research
Neuroscience and Neuropharmacology Research